STAT1 and neoplasm: Patients that respond to PD-1 blockade also exhibited increased expression of STAT1, CXCL9, CXCL10, GZMB, CD8A, and CD8B, which is consistent with our observation in tumor model with IFNα-MSC treatment (Fig. 7B).